CN102948733B - 一种特殊食用生命营养液的生产方法和配方 - Google Patents
一种特殊食用生命营养液的生产方法和配方 Download PDFInfo
- Publication number
- CN102948733B CN102948733B CN201110241839.0A CN201110241839A CN102948733B CN 102948733 B CN102948733 B CN 102948733B CN 201110241839 A CN201110241839 A CN 201110241839A CN 102948733 B CN102948733 B CN 102948733B
- Authority
- CN
- China
- Prior art keywords
- liver
- blood
- human body
- acid
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 12
- 239000007788 liquid Substances 0.000 title claims abstract description 11
- 230000035764 nutrition Effects 0.000 title abstract description 6
- 238000004519 manufacturing process Methods 0.000 title description 16
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 235000008708 Morus alba Nutrition 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 8
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 6
- 240000007087 Apium graveolens Species 0.000 claims description 5
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 5
- 235000010591 Appio Nutrition 0.000 claims description 5
- 235000006264 Asimina triloba Nutrition 0.000 claims description 5
- 241000255789 Bombyx mori Species 0.000 claims description 5
- 235000009467 Carica papaya Nutrition 0.000 claims description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 5
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 5
- 240000004307 Citrus medica Species 0.000 claims description 5
- 235000001938 Citrus medica Nutrition 0.000 claims description 5
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims description 5
- 244000077995 Coix lacryma jobi Species 0.000 claims description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 5
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 5
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 5
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 5
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 5
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 5
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 5
- 240000000171 Crataegus monogyna Species 0.000 claims description 5
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 5
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 5
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 5
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 5
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 5
- 241000756137 Hemerocallis Species 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims description 5
- 235000009496 Juglans regia Nutrition 0.000 claims description 5
- 241000218231 Moraceae Species 0.000 claims description 5
- 240000000249 Morus alba Species 0.000 claims description 5
- 241000237502 Ostreidae Species 0.000 claims description 5
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 5
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 5
- 244000046146 Pueraria lobata Species 0.000 claims description 5
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 5
- 241000219784 Sophora Species 0.000 claims description 5
- 240000004922 Vigna radiata Species 0.000 claims description 5
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 5
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 5
- 235000020636 oyster Nutrition 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 235000020234 walnut Nutrition 0.000 claims description 5
- 244000189799 Asimina triloba Species 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- 244000111489 Gardenia augusta Species 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 4
- 241000018646 Pinus brutia Species 0.000 claims description 4
- 235000011613 Pinus brutia Nutrition 0.000 claims description 4
- 244000197580 Poria cocos Species 0.000 claims description 2
- 235000008599 Poria cocos Nutrition 0.000 claims description 2
- 244000234609 Portulaca oleracea Species 0.000 claims 1
- 235000001855 Portulaca oleracea Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 11
- 238000005303 weighing Methods 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract 2
- 238000009924 canning Methods 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 25
- 230000000694 effects Effects 0.000 description 21
- 239000008280 blood Substances 0.000 description 17
- 210000004072 lung Anatomy 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 239000002253 acid Substances 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229910052742 iron Inorganic materials 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241000283073 Equus caballus Species 0.000 description 4
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010039966 Senile dementia Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 235000014676 Phragmites communis Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000002893 slag Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 235000016804 zinc Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000004470 DL Methionine Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000009525 Myocarditis Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000007287 cheilitis Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000021022 fresh fruits Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000007333 Brain Concussion Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 206010010075 Coma hepatic Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000013875 Heart injury Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000008425 Protein deficiency Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002467 anti-pepsin effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 208000005135 methemoglobinemia Diseases 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000004908 prostatic fluid Anatomy 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000021460 special beverage Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了人体生命营养液的配制方法,包括以下步骤:步骤1:产品原料组成;2:原料组成的比例;3:高温蒸煮的具体实施方法,即选料、衡器定量、高温蒸煮、过滤、勾对,再次过滤罐装,得到的是有色液体,称为生命营养液,上述方法简单,适用于工业规模化大生产。
Description
技术领域
本发明使用特殊饮料的生产方式,特别是人体生命营养液的配方和剂量比例的合成生产技术。
背景技术
人体生命营养液使用的农副产品为原料,原料来源广泛,产品营养成份有:17种氨基酸、蛋白质、维生素C、维生素E、维生素B1、维生素B2、锌、铁、钙、硒、磷,广泛地适合各类中风人群饮用,各类食道癌症人群饮用,各类肝病病症人群饮用,各类肺病人群饮用贪血,各类心脏病病症人群饮用,慢性胃病症人群饮用,老年痴呆病症人群饮用,贫血人群饮用,便秘人群饮用,目前中国消费市场上的所有饮料没有有此功能,而人体生命营养液生产方式简单,有利于规模工业化大生产。
发明内容
本发明的目的在于提供产品的配方和剂量,以及制造方法。实现本发明的技术具体实施方式有以下步骤:
步骤1、水处理:自然水处理成纯净水。2、将水和原材料配比进入容器中加温,原料有桑叶1%、菊花1%、槐花1%、蚕蛹1%、佛手0.5%、栀子0.5%、陈皮0.5%、决明子1%、荞麦1%、薏苡仁1%、枸杞0.5%、黑芝麻0.5%、桑葚0.8%、山楂1%、茯芩0.5%、葛根0.5%、山药2%、木瓜0.5%、马齿菜1%、牡蛎0.5%、核桃仁0.5%、桔梗0.5%、绿豆0.8%、金针菜0.5%、松毛3%、黑木耳0.5%、嫩桑枝0.5%、药芹1%、胡萝卜1%。3、过滤。4、杀菌灌装。5、封盖。6、检验。7、成品堆放。本发明与市场现有饮料相比,其显著优点:1、方法简单适用于工业化大生产;2、收率高、产品质量好;3、无环境污染;4、成本低;5、劳动力强度不大。本发明最大优点是在于:1、能调节农业生产结构、高效农业和森林公园展现在产品的原材料来源之中,有效地带动农业的发展;2、生产简单、收率高、产品的质量好,适合饮用人群广泛,适用性强。
具体实施方法
本发明的人体生命营养液的配方和生产方法,有以下步骤,简称:SOP生产流程即实施方法,另附“一种特殊食用生命营养液配制生产方法”示意图-图1。
一、原料组织及配方
1、原料有:桑叶、菊花、槐花、蚕蛹、佛手、栀子、陈皮、决明子、荞麦、薏苡仁、枸杞、黑芝麻、桑葚、山楂、茯芩、葛根、山药、木瓜、马齿菜、牡蛎、核桃仁、桔梗、绿豆、金针菜、松毛、黑木耳、嫩桑枝、药芹、胡萝卜。
二、原料配比及计量
2、原料以纯净水配比即100%比原料,分别是:桑叶1%、菊花1%、槐花1%、蚕蛹1%、佛手0.5%、栀子0.5%、陈皮0.5%、决明子1%、荞麦1%、薏苡仁1%、枸杞0.5%、黑芝麻0.5%、桑葚0.8%、山楂1%、茯芩0.5%、葛根0.5%、山药2%、木瓜0.5%、马齿菜1%、牡蛎0.5%、核桃仁0.5%、桔梗0.5%、绿豆0.8%、金针菜0.5%、松毛3%、黑木耳0.5%、嫩桑枝0.5%、药芹1%、胡萝卜1%。
三、原料选定
3、把每个所需要的植物原料进行手选,去除霉、坏原料。
4、所需要的原料定型后用纯净水清洗干净。
5、完成清洗后原料进入32-34℃温度容器中燥干。预冷1小时。
四、衡器运量
6、把预冷后的所需的植物原料分为颗粒型、木本型、草本型。
7、按纯净水的百分比、按配方所需要的原料进行衡器定量。
五、预热
8、先把颗粒型、木本型的原料容合后,进入高温容器中加入按配方的百分比所需的纯净水、封盖,将容器温度调到97℃-99℃,当温度到达所需要的温度时启动搅拌器进行搅拌,并衡温30分钟。
9、30分钟过后,加入所需要的草本型植物原料。5分钟后,将温度调到54℃-56℃之间。
10、当温度到达时衡温7-8分钟。当衡温的温度到达时停止搅拌,并把温度调到20℃。
11、温度到达20℃后,用350-400℃的丝网过滤、去渣,加入果质汁、防腐剂,再次进行2-3分钟搅拌,当时间到达时停止搅拌。
12、再次进行400-450℃丝网进行过渣、去渣后进入罐装工艺线。
13、新鲜果菜剂的提取方法:药芹、胡萝卜、新鲜果菜用纯净水洗净干燥后,用压榨机压榨取新鲜剂液备用。
六、罐装
14、罐装前按食品生产条件的要求进行瓶子的消毒,干净后罐装、封口。
15、封口后用干净布物把瓶上抹干,抹干后贴标识。
16、贴完标识后进入大的包装物包装。
七、入库
17、大包装完毕后,进入防水、防湿的成品库,一般情况下堆放不超过7层。
八、运输
18、运输要求与成品库要求一样,堆放不得过高,防止包装损坏。
分解人体生命营养液的营养成份,在人体内的作用:
苏氨酸:是人体必需要的氨基酸,对人体维持人体氨基酸的平衡起着重要作用。
丝安酸:对解除孤独症有重要帮助。
谷氨酸:在人体内蛋白质代谢中占重要地位,主要对肝昏迷,改善儿童智力发育有着重要帮助。
脯氨酸:是骨构成胶原蛋白的主要材料,起着壮骨作用的帮助。
甘氨酸:是人体必需氨基酸,在体内起到新陈代谢作用,能抗酸、抗消化性胃溃疡,对治疗忧郁症,延缓肌肉的退化,对底血糖症有疗效的重要帮助。同时能消除体味和口臭、美容美体有作一定的特殊帮助作用。
丙氨酸:对于人的成长与代谢具有重要作用的帮助。
缬氨酸:是人体必需氨基酸,也是儿童的必需的氨基酸。
甲硫氨基酸:对人体起到强化营养,弥补天然蛋白质不足,平衡氨基酸作用,人体的甲硫氨基酸平衡,可消除头发变脆,骨头变脆的现象,与叶酸等合成,可以防御肿瘤的生成。
亮安酸:是人体的必需氨基酸。
酪氨酸:是甲状腺荷尔蒙等生合成原料,是生成黑色素的基础物质,尚可减少脂肪的堆积。
苯基丙安基酸:是人体必需安基酸,在神经传异方面起着重大作用,它能控制疼痛,提高人的性欲,使人的饥饿感降低,有助于提高成年人思维和行动的敏捷。
赖安酸:在人体代谢中起着重要作用,也是必需安基酸对人体的正常发育,促进康复有着重要作用。
组安酸:对成人为非必要安基酸,但对幼儿来说有助于婴幼儿的发育,是必需安基酸。
精氨酸:是直接参与人体中制造一氧化氧,一氧化氧是血压的主要调节因子,有双向调节血压,有助于前列腺炎,甚至有助于尿毒症。具有神奇的生理调节功能,是免疫系统对付细菌、病毒、肿瘤细胞等病原体的有效武器,很大的作用能使人体细胞相互之间得以沟通,不需要任何中介就可以快速扩散通过生物 膜,在人体动脉、神经等防御体素中都能产生,能抑制炎症,生成白血球,使食物在人体加速运动,使肠胃系统正常运作,能够降低空气进入人体的阻力,使呼吸更加顺畅,能排尿节制,使得膀胱能够储存更多的尿液,通过扩张血管壁,使男性阴茎正常勃起,调控血压和血水板凝聚的抑制等生理作用。在生命体系中,细胞释放的一氧化氧量是很少,一氧化碳在10-100mmOl/L的低浓度下,就可以发挥其生理作用,但人体对一氧化氧的需求并非越多越好,过度释放一氧化氧或调节浓度高可致高铁血红蛋白血症,神经衰弱综合症,慢性呼吸道炎症,心脏损伤、冠心病。抑制一氧化氧分泌,具有消炎的作用,可以抑制关节炎等疾病,而释放和促进释放一氧化氧就有着治疗心血管疾病,肺局部血压增高等疾病的作用,有效地控制生物体内的一氧化氧的浓度或活性,对于治疗脑振荡,阿尔茨海默氏痴呆和帕金森氏病都具有非常诱人的前景。再通过黄酮等其他成份进一步巩固修复病症。
植物蛋白质:是构成人体内一切细胞的基本构成物质,包括催化体内各种生化反应的酶,调节机体生长、发育并行使正常生理功能的激素,抵御外来细菌、病毒的抗体及免疫类物质以及形成机体的渗透压,引发机体的各种活动。
维生素C:是人体胶原蛋白合成的重要辅助因子,促进钙、铁的吸收,对牙龈出血、溃烂以及坏血病,伤口愈合不良及神经系统症状或者出现肌肉萎缩,心脏衰竭在治疗方面有一定的帮助作用。有效预防骨骼松软、骨折。它可以促进细胞间的合成,也可以促进合成维生素D、皮质激素和性激素。也能抑制亚硝酸胺的合成,从而具有防癌的作用。还可以预防营养性贫血,降低胆固醇,预防动脉粥样硬化。同时有助于维护正常视力、感冒、肺炎、脑膜炎、风温热、肺结核、白喉、前列腺炎、耳、眼、鼻窦炎、扁桃腺炎、痛风、胃或十二指肠溃,都有缓解疼痛的效果,也能预防化学物质即:铅、溴、砷、苯等中毒,几小时内能使体温开始下降,逐渐回复到正常的体温,肝炎及单核白血球增多症的病人可加大维生素C和泛酸可避免病情恶化。促进前列腺液和淋巴液的分泌,使机体产生干扰素和抗毒素,从而起到免疫和抗病毒的作用,也是预防感冒、骨折有一定的作用。
维生素E:可减少脑细中一种被称作“脂褐质”的物质,这种物质是组织细胞衰老具有极重要的作用和严重的肌肉萎缩症人群,肾上腺及脑下腺,是保护骨骼肌、心肌、平滑肌和心血管所不可缺少的营养素,与铁、蛋白质、维生素B6结合,通常使贫血人群很快恢复正常。这种褐素阻止酶将血液中的凝块溶解,而形成静脉曲张,静脉炎、肺栓塞及中风,以及因缺氧所引起的心绞痛的心脏痛。可保持细胞活力保护细胞膜的透过性,防止细胞膜破裂、阻止脂肪过氧化,改善皮肤的弹性,使皮肤更显光彩,使人们体内各种生物膜的强大“保护神”,可使它们免受过氧化物的损害,可增强肝的解毒功能。促进胆碱的利用。对于肌肉无力也有治疗效果的帮助。
维生素B:主要是对周围神经炎,下肢水肿和心肌炎症或头痛失眠,便泌、疲倦、思维混乱、健忘、腹病、胀气、眩晕及食欲不振有一定的治疗方面的帮助作用,是维持生命的重要营养素之一,它构成辅酶、维持体内正常代谢,维持正常的神经活动,帮助心脏持久地工作,抑制胆碱酯酶的活性,促进胃肠蠕动,增强消化系统功能的作用。促进脑细胞的活动需要由糖所转化的能量,以及减少丙酮酸及乳酸。
维生素B2:对口角炎、唇炎、舌炎、脂益性皮炎、角膜血管增生及阴囊炎有一定的治疗帮助作用,与铁的吸收、储存及利用有关,也有抗氧化作用,其它作用主要是在氨基酸、脂肪和碳水化合物的代谢中起着重要作用,如果没有维生素B2参与,细胞的生长就会停滞。优其与维生素A及维生素E结合的人体需要,对视觉模糊、夜晚的视力正常以及白内障有着一定的康复效果。
锌:锌是人体必需微量元素之一,主要表现在于肌肉、骨骼、皮肤、视网膜、脉络膜、前列腺等中,能促进人体多种酶的活性和多种蛋白质核酸的合成,直接参与基因表达调控,从而加速人体的生长发育,促进维生素A的代谢,维持细胞膜稳定,减少毒素吸收和组织损伤,对生物膜的屏障功能,转远功能及与受体的结合有着重要作用。是食道癌的天敌。
铁:铁元素是红蛋白的中心原子,是酶的组成部分,参与能量代谢,是构成血红蛋白,肌红蛋白以及某些呼吸酶的成份,参与体内氧和二氧化碳的转远,交换和组织呼吸过程,此外,铁述参与抗体的产生, 脂类在血液中的转远以及药物在肝脏的解毒等重要功能。铁的吸收和利用,与维生素C、B2、叶酸结合、效果更佳。
钙:钙是构成骨骼和牙齿外还可维持神经与肌肉的正常生理活动,包括神经与肌肉的兴奋,神经冲动的传导,心脏的正常转动,并且维持细胞的正常生理功能,钙对参与细胞代谢的许多酶都有调节作用,参与血凝过程、激素分泌、维持体液酸碱平衡以及细胞内胶质的稳定性,精子和卵子受精的过程中也需要钙、脑的发育、小儿的成长都离不开钙,对骨质疏松、骨折、夜间盗汗、手足抽搐、夜啼易惊,厌食及烦燥不安,儿童多动症、贫血、生长迟缓、学习能力和记忆力下降有一定的康复作用。便秘、失眠、蛀牙、动脉硬化、高血压以及老年痴呆症与缺钙或钙的流失有一定关连。与磷、D结合的比例协调可增强家庭和谐。
硒:它是人必需的微量元素之一,主要生理功能是抗氧化,从而保护细胞膜与维生素E具有重要的协同作用,可以消除活性氧自由基、能选择性抑制和杀伤癌细胞,增强机体免疫力,并能降低化疗和放疗引起的机体损伤,提高机体的耐受性,是预防多种疾病的好帮手,对肺癌、肝癌、食管癌多种癌症场有明显的预防和治疗作用,也是防治动脉粥样硬化,冠心病脑血栓的有效措施,对心肌炎,心肌病等有效强的康复效果,使肝炎的发病率明显降低,保护肝细胞改善功能,对难治愈的慢性肝炎、肝腹水有显著疗效,对慢性胃炎、哮喘、慢性支气管炎、妊娠高血压、不孕症、乳腺增生,以及克山病、大骨节病、糖尿病、关节炎、白内障、溶血性、贫血等均有防治效果,还有拮抗汞、钙等剧毒重金属元素,排毒的特殊功能。
磷:它能提高人体大脑所需要的脑磷脂卵磷脂比例的作用,卵磷脂是胆碱及肌醇两种维生素B的最佳来源,便能把附着在动脉血管壁上放大的胆固醇颗粒分解成微小粒小,不会造成血管硬化、软化血管壁、改善血液品质,促进血液循环,对高血压、冠心病、心肌梗塞、脑中风以及老年性痴呆等症状均有预防效果,与钙、锰脂肪酸、蛋白质、维生素A、B、C、E,结合效果更佳。
根据本产品检测的营养指标的数据分析以及对人体的作用性,命名为人体生命营养液。下面根据中国药典(2010版1、2、3卷)的内容,再从中医药观点来分解,表述植物的功能性:
桑叶:甘、苦、寒、归肺、肝经。作用是疏散风热、清肺润燥、平肝明目、抗菌、降血糖,促进蛋白质合成、降血脂等。
菊花:辛、甘、苦、微寒、归肺、肝经。疏散风热、平肝明目、抗菌、护张、冠状动脑,增加冠脉血流量、抗肝损伤。
槐花:苦、微寒、归肝、太肠经。凉血止血、汗肝泻火、肝热目赤、头痛眩晕。促凝血、止血、抗菌、利尿。
蚕蛹:苦、咸、辛、平。归肝、肺、胃经。具有息风止痉、祛风止痛、解毒散结。
佛手:辛、苦、温。归肝、脾、胃、肺经。疏肝理气和中止痛、燥湿化痰止咳。
栀子:苦、寒。归心、肝、肺、胃、三焦经。泻火除烦、凉血止血、解毒、清利湿热。
陈皮:辛、苦、温。归肺、脾经。理气健脾、燥湿化痰。理气健脾、燥湿化痰。
决明子:甘、苦、咸、微寒。归肝、大肠经。清肝明目、润肠通便。
荞麦:苦、平。归肺、脾、胃经、清热解毒、清肺化痰、健脾消食。
嫩桑枝:苦、平、归肝经。祛风通络。
薏苡仁:甘、淡、微寒。归脾、胃经。利水渗湿、清热排脓。
枸杞子:甘、平。归肝、肾经。滋补肝肾、益精明目、滋阴润肺。
黑芝麻:甘、平。归肺、肾、大肠经。补肝肾、益精血、润燥滑肠。
桑葚:甘、寒。归肝、肾经。兹阴补血、生津润燥。
山楂:甘、酸、温。归肝、脾、胃经。消食化积、行气散瘀。
茯苓:甘、淡、平。归心、脾、胃经。利朋渗湿、健脾宁心。
葛根:甘、辛辣。归脾、胃经。解肌退热、透发麻疹,生津止渴。开阳止泻、解毒和药。
山药:甘、平。归脾、肺、肾经。补气止咳、补脾止泻、补肾涩精。
木瓜:酸、温。归肝、脾经。舒筋活络,化湿和胃。
马齿菜:酸、寒。归大肠经。清热解毒止痢,凉血止血。
牡蛎:咸、微寒。归肝、胆、胃经。平肝替阳,收敛固涩,软坚散结。
核桃仁:甘、温。归肾、肺、大肠经。补肾助阳、温肺止咳,润肠通便。
桔梗:苦、辛、平。归肺经。宣肺祛痰,排脓、利咽。
绿豆:甘、寒。归心、胃经。清热解毒,消暑利悄。
金针菜:甘、凉。归脾、肺经。清热解毒,消炎利尿,健胃养血,平肝补血。
因此本发明人体生命营养液产品,营养数据结合配方原料植物的属性及功能性,对此,本发明生命营养液均适合各类中风人群,各类食道癌人群,各类胃病、老年痴呆人群,便秘、感冒、眼睛怕光人群饮用。但配方中菊花属于季节性配制。本产品切忌:肉,以及咸、酸性食品。
Claims (1)
1.一种人体特殊食用生命营养液,其特征在于:所述生命营养液由以下原料制成:桑叶1%,菊花1%,槐花1%,蚕蛹1%,佛手0.5%,栀子0.5%,陈皮0.5%,决明子1%,荞麦1%,薏苡仁1%,枸杞0.5%,黑芝麻0.5%,桑葚0.8%,山楂1%,茯苓0.5%,葛根0.5%,山药2%,木瓜0.5%,马齿苋1%,牡蛎0.5%,核桃仁0.5%,桔梗0.5%,绿豆0.8%,金针菜0.5%,松叶3%,黑木耳0.5%,嫩桑枝0.5%,药芹1%,胡萝卜1%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110241839.0A CN102948733B (zh) | 2011-08-23 | 2011-08-23 | 一种特殊食用生命营养液的生产方法和配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110241839.0A CN102948733B (zh) | 2011-08-23 | 2011-08-23 | 一种特殊食用生命营养液的生产方法和配方 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102948733A CN102948733A (zh) | 2013-03-06 |
CN102948733B true CN102948733B (zh) | 2014-03-26 |
Family
ID=47758559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110241839.0A Active CN102948733B (zh) | 2011-08-23 | 2011-08-23 | 一种特殊食用生命营养液的生产方法和配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102948733B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103349315B (zh) * | 2013-06-14 | 2016-03-09 | 朱奕 | 一种保健口服液及其制备方法 |
CN108434256A (zh) * | 2018-05-18 | 2018-08-24 | 杨波 | 一种养肝明目解毒排脂恢复肝脏代谢功能的中药配方 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1089486A (zh) * | 1993-07-26 | 1994-07-20 | 广西中医学院 | 一种保健调养液及其制备方法 |
CN1096426A (zh) * | 1994-03-28 | 1994-12-21 | 王大为 | 鳗鱼营养液及其系列保健饮品的生产方法 |
JP2010004792A (ja) * | 2008-06-26 | 2010-01-14 | Taiyo Kagaku Co Ltd | 液状食品組成物のチューブ流動性改善剤 |
-
2011
- 2011-08-23 CN CN201110241839.0A patent/CN102948733B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102948733A (zh) | 2013-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102524872B (zh) | 一种参肽氨基酸饮料 | |
CN103653147A (zh) | 一种小麦肽抗疲劳保健饮料及其制备方法 | |
CN103349284B (zh) | 一种桑椹酵素营养液及其制备方法 | |
CN102224891A (zh) | 一种糖醇蜂蜜苹果酱及其制备方法 | |
CN101366521B (zh) | 天然型功能食品 | |
CN105567771A (zh) | 一种猪皮小肽螯合物及其制备方法和应用 | |
CN101692917B (zh) | 脑营养饮料 | |
CN102048225B (zh) | 一种具有改善生长发育功能的红枣保健饮料 | |
CN104256246A (zh) | 一种阿胶红糖及其制备方法 | |
CN101253986B (zh) | 多功能营养复合保健饮料及其制备方法 | |
CN102948733B (zh) | 一种特殊食用生命营养液的生产方法和配方 | |
CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
CN102659917A (zh) | 一种从松花粉中分离制备粗蛋白及酶解肽类的方法 | |
CN102018158A (zh) | 一种芦荟果酱 | |
CN101983721B (zh) | 具有抗疲劳、补钙功能的苁蓉钙组合物 | |
CN101889685B (zh) | 一种天然植物保健品及制备方法 | |
CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
CN102524800A (zh) | 一种复合黄瓜籽粉及其制备方法 | |
CN110679816A (zh) | 一种能够增强免疫力的固体饮料及其制备方法 | |
CN103749885B (zh) | 纤美营养型牦牛乳蛋白质糖及其制备方法 | |
CN104013853B (zh) | 一种健肾补肾的组合物及其制备方法 | |
CN101530229A (zh) | 一种饮料配方 | |
CN104274483A (zh) | 一种新生源口服液及其制备方法 | |
CN106728502A (zh) | 一种降血糖药酒及其生产方法 | |
CN115153033A (zh) | 一种调理机体营养不均衡的复合小分子肽配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DD01 | Delivery of document by public notice |
Addressee: Yangzhou Wataru Hwan Lianke Industry & Trade Co.,Ltd. Qin Lian Bang Document name: Notification to Make Rectification |
|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice |
Addressee: YANGZHOU GENHENG LIANKE INDUSTRY AND TRADE Co.,Ltd. Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Qin Banglian Document name: payment instructions |